However, on week 4, tumors treated with Pmel-1 ACT escaped control and grew again in six of the seven animals, whereas mice receiving Pmel-1 x SLAMF6 -/- ACT survived longer, and three of the seven treated mice remained tumor-free for over 80 days (Figure 4H). The gene discussed is SLAMF6; the disease is neoplasm.